Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

[2007 Index Page]
 



[Code of Federal Regulations]
[Title 21, Volume 1]
[Revised as of April 1, 2007]
From the U.S. Government Printing Office via GPO Access
[CITE: 21CFR20.100]

[Page 211-212]
 
                        TITLE 21--FOOD AND DRUGS
 
CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN 
                                SERVICES
 
PART 20 PUBLIC INFORMATION--Table of Contents
 
        Subpart F Availability of Specific Categories of Records
 
Sec.  20.100  Applicability; cross-reference to other regulations.


    (a) The provisions set forth in this subpart or cross-referenced in 
paragraph (c) of this section state the way in which specific categories 
of Food and Drug Administration records are handled upon a request for 
public disclosure. The exemptions established in subpart D of this part 
and the limitations on exemptions established in subpart E of this part 
shall be applicable to all Food and Drug Administration records, as 
provided in Sec. Sec.  20.60 and 20.80. Accordingly, a record that is 
ordinarily available for public disclosure in accordance with this part 
or under other regulations is not available for such disclosure to the 
extent that it falls within an exemption contained in subpart D of this 
part except as provided by the limitations on exemptions specified in 
subpart E of this part.
    (b) The Commissioner, on his own initiative or on the petition of 
any interested person, may amend this subpart or promulgate and cross-
reference additional regulations to state the status of additional 
categories of documents to settle pending questions or to reflect court 
decisions.
    (c) In addition to the provisions of this part, rules on the 
availability of the following specific categories of Food and Drug 
Administration records are established by regulations in this chapter:
    (1) Section 305 hearing records, in Sec.  7.87(c) of this chapter.
    (2) Flavor ingredient records and notes, in Sec.  101.22(i)(4)(iv) 
of this chapter.
    (3) Environmental assessments; finding of no significant impact, in 
Sec.  25.51 of this chapter, or draft and final environmental impact 
statements, in Sec.  25.52 of this chapter.
    (4) Color additive petitions, in Sec.  71.15 of this chapter.
    (5) Food standard temporary permits, in Sec.  130.17(k) of this 
chapter.
    (6) Information on thermal processing of low-acid foods packaged in 
hermetically sealed containers, in Sec.  108.35(l) of this chapter.
    (7) Food additive petitions, in Sec. Sec.  171.1(h) and 571.1(h) of 
this chapter.
    (8) Action levels for natural and unavoidable defects in food for 
human use, in Sec.  110.110(e) of this chapter.
    (9) Drug establishment registrations and drug listings, in Sec.  
207.37 of this chapter.
    (10) Investigational new animal drug notices, in Sec.  514.12 of 
this chapter.
    (11) New animal drug application files, in Sec.  514.11 of this 
chapter.
    (12) Investigational new animal drug notice and a new animal drug 
application file for an antibiotic drug, in Sec.  514.10 of this 
chapter.
    (13) Methadone patient records, in Sec.  291.505(g) of this chapter.
    (14) Investigational new drug notice, in Sec.  312.130 of this 
chapter.
    (15) Labeling for and lists of approved new drug applications, in 
Sec.  314.430 of this chapter.
    (16) Master file for a new drug application, in Sec.  312.420 of 
this chapter.
    (17) New drug application file, in Sec.  314.430 of this chapter.
    (18) Data and information submitted for in vitro diagnostic 
products, in Sec.  809.4 of this chapter.
    (19) Data and information submitted for OTC drug review, in Sec.  
330.10(a)(2) of this chapter.
    (20) Investigational new drug notice for an antibiotic drug, in 
Sec.  431.70 of this chapter.
    (21) Antibiotic drug file, in Sec.  314.430 of this chapter.
    (22) Data and information submitted for biologics review, in Sec.  
601.25(b)(2) of this chapter.
    (23) Investigational new drug notice for a biological product, in 
Sec.  601.50 of this chapter.
    (24) Applications for biologics licenses for biological products, in 
Sec.  601.51 of this chapter.
    (25) Cosmetic establishment registrations, in Sec.  710.7 of this 
chapter.

[[Page 212]]

    (26) Cosmetic product ingredient and cosmetic raw material 
composition statements, Sec.  720.8 of this chapter.
    (27) Cosmetic product experience reports, in Sec.  730.7 of this 
chapter.
    (28) Device premarket notification submissions, in Sec.  807.95 of 
this chapter.
    (29) Electronic product information, in Sec. Sec.  1002.4 and 
1002.42 of this chapter.
    (30) Data and information submitted to the Commissioner or to 
classification panels in connection with the classification or 
reclassification of devices intended for human use, in Sec.  860.5 of 
this chapter.
    (31) Data and information submitted in offers to develop a proposed 
performance standard for medical devices, in Sec.  861.26 of this 
chapter.
    (32) Investigational device exemptions in Sec.  812.38 of this 
chapter.
    (33) Health claims petitions, in Sec.  101.70 of this chapter.
    (34) Premarket approval application, in Sec.  814.9 of this chapter.
    (35) Report of certain adverse experiences with a medical device, in 
Sec.  803.9 of this chapter.
    (36) Disqualification determination of an institutional review 
board, in Sec.  56.122 of this chapter.
    (37) Disqualification determination of a nonclinical laboratory, in 
Sec.  58.213 of this chapter.
    (38) Minutes or records regarding a public advisory committee, in 
Sec.  14.65(c) of this chapter.
    (39) Data submitted regarding persons receiving an implanted 
pacemaker device or lead, in Sec.  805.25 of this chapter.
    (40) Humanitarian device exemption application, in Sec.  814.122 of 
this chapter.
    (41) Premarket notifications for food contact substances, in Sec.  
170.102 of this chapter.
    (42) Registration of food facilities, in Sec.  1.243 of this 
chapter.

[42 FR 15616, Mar. 22, 1977, as amended at 42 FR 19989, Apr. 15, 1977; 
42 FR 42526, Aug. 28, 1977; 42 FR 58889, Nov. 11, 1977; 43 FR 32993, 
July 28, 1978; 51 FR 22475, June 19, 1986; 54 FR 9038, Mar. 3, 1989; 58 
FR 2533, Jan. 6, 1993; 59 FR 536, Jan. 5, 1994; 61 FR 33244, June 26, 
1996; 62 FR 40592, July 29, 1997; 64 FR 56448, Oct. 20, 1999; 67 FR 
13717, Mar. 26, 2002; 67 FR 35729, May 21, 2002; 68 FR 58965, Oct. 10, 
2003]




Back to Top

© 2007 Betterchem Corp.